The PRESTIGE-AF project, funded by the European Commission, brings together scientists and clinicians from across Europe to determine the best way to reduce the risk of further stroke in people with atrial fibrillation (AF), a common type of irregular heartbeat, who have recently had a bleed in their brain, called an intracerebral haemorrhage (ICH).
PRESTIGE-AF stands for: PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation.
At the core of the PRESTIGE-AF project is a clinical trial alongside three optional sub-studies that participants in the trial can take part in.